Uluslararası Bilimsel Toplantı Bildirileri

96.Gürdal M., Kireçci S., Pirinçci N., Karaman İ., Türkeri L. Correlation between duration of varicocele and apoptolar tn experimental model. American Urological Association Annual Meeting, Chicago, USA, April 26-May 1, 2003.

 

95.Türkeri L., Özyürek M. Association of prostate cancer with vitamine D receptor gene polymorphism. 18th Annual Meeting of Urological Research Society, İzmir, Turkey, September 13-15, 2001.

 

94.Özveren B., Türkeri L., Özyürek M. Vascular endothelial growth factor and thrombospondin-1 mRNA expression correlates with poor prognosis in human transitional cell carcinoma. 15th Congress of European Society for Urological Research, Istanbul, Turkey, October 5-7, 2000.

 

93.Türkeri L., Özyürek M. Loss of imprinting of Insulin lLike Growth Factor 2 (IGF-2) in transitional cell carcinoma of the bladder. 15th Congress of European Society for Urological Research, Istanbul, Turkey, October 5-7, 2000.

 

92.Türkeri L., Özyürek M. Augmented cytotoxicity of estramustine in prostate cancer cell lines by N-Acetyl-L-Cysteine. Innovators in Urology, 3rd International Meeting, Dublin, Ireland, September 14-16, 2000.

 

91.Özveri H., Çevik İ., Çam K., İnce Ü., Türkeri L., Akdaş A. Prospective evaluation of twelve core peripheral zone biopsies in improving prostate cancer detection. 5th International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer, Houston, Texas, USA, April 28-29, 2000.

 

90.Türkeri L., Yıldırım A., Özveri H., Kaya C., Akdaş A. Pre-operative clinical parameters as a predictor of the pathological features of radical retropubic prostatectomy. 5th International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer, Houston, Texas, USA, April 28-29, 2000.

 

89.Türkeri L., Ayaz O., Özyürek M., Akdaş A. Cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines: TGF-b modulation and expression of cell cycle control genes. The 3rd World Congress on Urological Research, Paris, France, September 30-October 3, 1999, p. 518.

 

88.Türkeri L., Ayaz O., Özyürek M., Akdaş A. Role of TGF- modulation in hormone refractory prostate cancer cell lines. 16th Annual Meeting of Urological Research Society, Bordeaux, France, September 16-18, 1999, p. 1.

 

87.Özveri H., Çam K., Özveren B., İnce Ü., Türkeri L., Akdaş A. Early diagnosis of prostate cancer in a setting of private office based urologic clinic. 6th Congress of the Mediterranean Urological Association, Cairo, Egypt, September 6-9, 1999, p. 38.

 

86.Akdaş A., Çam K., Özveri L., Türkeri L. Role of DRE, PSA and Gleason score in the prediction of extracapsular disease. 6th Congress of the Mediterranean Urological Association, Cairo, Egypt, September 6-9, 1999, p. 35.

 

85.Çam K., Yıldırım A., Ayaz O., Özveri H., Türkeri L., Akdaş A. Efficacy of neoadjuvant chemotherapy in invasive bladder cancer. 6th Congress of the Mediterranean Urological Association, Cairo, Egypt, September 6-9, 1999, p. 58.

 

84.Özveren B., Türkeri L., Özyürek M., Akdaş A. Prognostic role of colony formation efficiency of human transitional cell carcinoma cell lines. 6th Congress of the Mediterranean Urological Association, Cairo, Egypt, September 6-9, 1999, p. 50.

 

83.Akdaş A., Çam K., Özveri H., Özveren B., Türkeri L. The significance of hypoechoic lesion directed biopsies and transition zone biopsies in improving the diagnostic ability in prostate cancer. 8th International Congress on Interventional Ultrasound, Copenhagen, Denmark, August 31- September 3, 1999, p. 41.

 

82.Akdaş A., Çam K., Türkeri L. US-guided prostatic biopsies and clinical relevance. 8th International Congress on Interventional Ultrasound, Copenhagen, Denmark, August 31- September 3, 1999, p. 35.

 

81.Türkeri L., Ayaz O., Özyürek M., Akdaş A. Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation. Innovators in Urology 2nd International Meeting, Oxford, UK, July 29-31, 1999, p. 36.

 

80.Haklar G., Çam HK., Yüksel M., Türkeri L., Şimşek F., Yalçın AS., Akdaş A. The role of reactive oxygen species and apoptosis in the pathogenesis of infertility in rat varicocele model. 17th International and 13th European Clinical Chemistry and Laboratory Medicine, Firenze, Italy, June 6-11, 1999.

 

79.Özveri H., Türkeri L., Yıldırım A., Özyürek M., Akdaş A. Effect of calcium channel blockers on apoptosis induced by renal ischemia. 14th Congress of the European Association of Urology. Stockholm, Sweden, April 7-11, 1999.

 

78.Yıldırım A., Türkeri L., Özyürek M., Akdaş A. Predictive value of nuclear overexpression of p53 and epidermal growth factor receptor in superficial transitional cell carcinoma of the bladder. 13th Congress of the European Society for Urological Oncology and Endocrinology, Innsbruck, Austria, October 1-3, 1998.

 

77.Özveren B., Türkeri L., Özyürek M., Akdaş A. The prognostic role of the colony formation efficiency of human transitional cell carcinoma cell lines. 13th Congress of the European Society for Urological Oncology and Endocrinology, Innsbruck, Austria, October 1-3, 1998.

 

76.Türkeri L., Özyürek M., Akdaş A. Prognostic value of the expression of epidermal growth factor receptor and its ligands in superficial bladder cancer. Urological Research Society 15th Meeting, Nara, Japan, September 12-15, 1998.

 

75.Türkeri L., Çam K., Akdaş A. Early diagnosis of prostate cancer in urology outpatient clinics. International Congress of Balkan Union of Oncology, Kuşadası, Turkey, September, 1998.

 

74.Türkeri L., Çam K., Özveri H., İlker Y., Akdaş A. The role of prostate specific antigen, digital rectal examination, transrectal ultrasonograhy and Gleason score in the prediction of extracapsular disease. International Congress of Balkan Union of Oncology, Kuşadası, Turkey, September, 1998.

 

73.Özveri H., Çam K., Ertuğrul A., Türkeri L., Akdaş A. Significance of free to total PSA ratio in patients with normal digital rectal examination, normal transrectal ultrasonography and intermediate total PSA levels. International Congress of Balkan Union of Oncology, Kuşadası, Turkey, September, 1998.

 

72.Türkeri L., Özveri H., Çam H K., Ertuğrul A., Akdaş A. Significance of hypoechoic lesion directed biopsies: Whether it is indicated or not. 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer, Tokyo, Japan, July 3-4, 1998.

 

71.Akdaş A., Türkeri L., Özveri H., Çam H K., Tarcan T. Early diagnosis of prostate cancer in urology outpatient department. 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer, Tokyo, Japan, July 3-4, 1998.

 

70.Özveri H., Çam H K., Özveren B., Türkeri L., Akdaş A. Significance of hypoechoic lesion directed biopsies and free to total PSA ratio in patients with normal digital rectal examination and intermediate total PSA levels. 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer, Tokyo, Japan, July 3-4, 1998.

 

69.Ertuğrul A., Türkeri L., Özveri H., Özyürek M., Akdaş A. Alteration of epidermal growth factor receptor (EGF-R) expression following ischemia of renal tissue. XIIIth Congress of European Association of Urology, Barcelona, Spain, March 21-25, 1998.

 

68.Toktaş G., Ünlüer E., Çalşkan M., Türkeri L., Kulaksızoğlu H., Mutar C. The effect of nuclear p53 deposition in superficial and invasive bladder tumors on grade, stage, recurrence, progression and survival. XIIIth Congress of European Association of Urology, Barcelona, Spain, March 21-25, 1998.

 

67.Akdaş A., Özveri H., Türkeri L., Tarcan T. Efficacy of transrectal ultrasonography (TRUS) and TRUS guided core biopsiesin the localization of prostate cancer. 24th World Congress of Societe Internationale d'Urologie, Montreal, Canada, September 7-11, 1997.

 

66.Türkeri L., Özyürek M., Yenice S., Ersev D., Akdaş A. Epithelial regression and decrease in serum PSA levels induced by short-term Doxazosin treatment in Benign prostatic hyperplasia. 24th World Congress of Societe Internationale d'Urologie, Montreal, Canada, September 7-11, 1997.

 

65.Atuğ F., Türkeri L., Özyürek M., Akdaş A. Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. 24th World Congress of Societe Internationale d'Urologie, Montreal, Canada, September 7-11, 1997.

 

64.Özveri H., Tarcan T., Ertuğrul A., Biren T., Türkeri L., Akdaş A. Early detection of localized prostate cancer in an outpatient population with prostatism symptoms. 24th World Congress of Societe Internationale d'Urologie Montreal, Canada, September 7-11,1997.

 

63.Emerk K., Çevik İ., Tarcan T., Türkeri L., Akdaş A. The role of free PSA in the diagnosis of prostate cancer. International Conference on PSA and Prostatic Disease. Llanberis, Wales, May 21-22, 1996

 

62.Emerk K., Çevik İ., Tarcan T., Türkeri L., Akdaş A. Age related changes in prostate specific antigen levels in benign prostate hyperplasia. International Conference on PSA and Prostatic Disease. Llanberis, Wales, May 21-22, 1996.

 

61.Akdaş A., Özveri H., Türkeri L., Tarcan T., Biren T. Efficacy of transrectal ultrasonography (TRUS) and TRUS-guided core biopsies in the localisation of prostate cancer. Seventh International Congress on Interventional Ultrasound, Copenhagen, Denmark, September 3-6, 1996.

 

60.Tarcan T., Özveri H., Biren T., Türkeri L., Gürmen N., Akdaş A. Significance of hypoechoic lesion directed biopsies in patients with normal digital rectal examination and intermediate serum prostate specific antigen levels. Third Seminar of the International Cooperative Study of Diagnostic Ultrasound in Prostatic Cancer, İstanbul, Turkey, June 15-16, 1996.

 

59.Tarcan T., Özveri H., Biren T., Türkeri L., Akdaş A. Screening for prostate cancer in Urology outpatient clinics. Third Seminar of the International Cooperative Study of Diagnostic Ultrasound in Prostatic Cancer, İstanbul, Turkey, June 15-16, 1996.

 

58.Erton ML., Türkeri L., Çevik İ., İlker Y., and Akdaş A. The impact of the expression of epidermal growth factor (EGF), transforming growth factor a (TGFa) and EGF receptor (EGFR) on the prognosis of superficial bladder cancer. AUA Ninety-First Annual Meeting, Orlando, May 4-9, 1996.

 

57.Akdaş A., Çevik İ., Tarcan T., Türkeri L., Emerk K. The impact of free PSA in early diagnosis of prostate carcinoma. First International Consultation on Prostate Cancer, Monaco, June 20-21, 1996.

 

56.Tarcan T., Özveri H., Biren T., Türkeri L., Akdaş A. Early diagnosis of prostate cancer in patients attending to urology outpatient clinics. Recent Advances in Prostate Cancer and BPH, De Doelen, Rotterdam, April 11-13, 1996.

 

55.Tarcan T., Özveri H., Biren T., Türkeri L. Akdaş A. Results of transrectal ultrasonography-guided biopsies in 100 consecutive patients with normal digital rectal examination and serum prostate specific antigen between 4-20 ng/ml. Recent Advances in Prostate Cancer and BPH, De Doelen, Rotterdam, April 11-13, 1996.

 

54.Şimşek F., Türkeri L., Çevik İ., Bircan K., and Akdaş A. The role of apoptosis in testicular dysfunction associated with varicocele. XIIth Congress of the European Association of Urology, Paris, France, September 1-4, 1996.

 

53.Türkeri L., Akdaş G., Akdaş A. Cell cycle associated changes in PC3 cell line treated with chemotherapy and calcium channel blockers. XIIth Congress of the European Association of Urology, Paris, France, September 1-4, 1996.

 

52.Türkeri L., Akdaş G., Akdaş A. The role of in vitro chemosensitivity tests to predict the clinical efficacy of antineoplastic agents used in transitional cell carcinoma of the bladder: Preliminary report. XIIth Congress of the European Association of Urology, September 1-4, 1996, Paris, France.

 

51.Türkeri L., Başaran M., Akdaş a. Cell cycle associated changes in a hormone resistant prostate cancer cell line treated with vinblastine and colony stimulating factors. 1st World Congress on Urological Research (ESUOE and SBUR), , Rotterdam, The Netherlands, September 1-3, 1995.

 

50.Türkeri L., Akdaş A. Incorporation of basic research into clinical urological practice. 4th Mediterranean Congress of Urology, Rhodes, Greece, September 6-10,1995.

 

49.Akdaş A., Tarcan T., Türkeri L., Biren T., İlker Y. The impact of prostate specificantigen (PSA), PSA density (PSAD) and Gleason score in the prediction of extracapsular disease in prostate carcinoma (CaP). AUA new York Section 93rd Annual Meeting. İstanbul, Turkey, October 7-14, 1995.

 

48.Y. Alican, İ. Çevik, L. Türkeri, F. Şimşek, T. Akoğlu, A. Akdaş HLA Subtype Analysis in Patients with Advanced Adenocarcinoma of the Prostate. 4th International Marmara Medical Days, Istanbul, Turkey, September 7-9, 1994.

 

47.Alkan İ.,Çevik İ., Türkeri L., Şimşek F., Akdaş A. Opretaive outcome assessment in patients with benign prostatic hyperplasia by AUA symptom score and uroflowmetry. 4th International Marmara Medical Days, Istanbul, Turkey, September 7-9, 1994.

 

46.ürkeri L. Sakr W., Grignon D J., Pontes E J., and Macoska J A. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, PIN and malignant prostate tissue. Societe Internationale D’Urologie, 23rd Congress, Sydney, September 18-22, 1994.

 

44.       Akdaş A., Tarcan T., Türkeri L., Küllü S., İlker Y.: The use of prostate specific antigen (PSA), PSA density (PSAD) and clinical stage in the prediction of local, extracapsular and nodal disease in prostate carcinoma (PCa). 2nd Euro-American Conference on Urological Diseases. Athens, Greece, August 28-31, 1994.

 

43.       Tarcan T., Türkeri L., İlker Y., Korten V., Akdaş A.: The role of antibiotic prophylaxis in extracorporeal shock wave lithotripsy (ESWL) in low risk group of patients. 9th Mediterranean Congress of Chemotherapy. Milan, Italy, June 12-17, 1994.

 

42.       Türkeri L., Tarcan T., Özveri H., Biren T., Küllü S., Akdaş A.: Correlation of transrectal ultrasonography findings and tru-cut biopsies with the final pathological results in radical prostatectomy patients. The Satellite Meeting of The 7th Congress of World Federation for Ultrasound in Medicine and Biology. Kyoto, Japan, July 14-15, 1994.

 

41.       Akdaş A., Tarcan T., Türkeri L., Çevik İ., Biren T., Gürmen N: The diagnostic accuracy of digital rectal examination, transrectal ultrasound, prostate specific antigen, and prostate speific antigen density in prostate carcinoma. The Satellite Meeting of The 7th Congress of World Federation for Ultrasound in Medicine and Biology. Kyoto, Japan, July 14-15, 1994.

 

40.       Türkeri L., Dillioğlugil Ö., Tarcan T., Gürmen N., Küllü S., Akdaş.: Transrectal ultrasonograpy versus digital guided biopsies on patients with palpable lesions on digital rectal examination suggesting prostate cancer. The 7th Congress of World Federation for Ultrasound in Medicine and Biology. Sapporo, Hokkaido, Japan, July 17-22, 1994.

 

39.       Türkeri L., Sakr W., Powell I J., Pontes E J., Macoska J A. Analysis of Y chromosome loss in relation to age and disease status in prostate cancer by combined PCR and FISH techniques. XIth Congress of the European Association of Urology, Berlin, July 13-16, 1994.

 

38.       Türkeri L. Sakr W., Grignon D J., Pontes E J., and Macoska J A. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, PIN and malignant prostate tissue. AUA 89th Annual Meeting, San Francisco, May 14-19, 1994.

 

37.       Türkeri L., Lum L.G., and Haas G.P.: Continuous bladder irrigation in prevention of hemorrhagic cystitis due to cyclophosphamide based conditioning treatment for bone marrow transplantation. AUA North Central Section 67th Annual Meeting. Milwaukee, Wisconsin, September 28-October 2, 1993.

 

36.       Türkeri L., Macoska J.A., Wykes S., Sakr W.A., and Pontes J.E.: Comparative analysis of epidermal growth factor receptor expression in benign and malignant tissue from radical prostatectomy specimens. AUA North Central Section 67th Annual Meeting. Milwaukee, Wisconsin, September 28-October 2, 1993.

 

35.       Türkeri L., Sakr W.A., Wolman S.R., Micale M.A., Grignon D.J., Powell I.J., Pontes J.E., and Macoska J.A.: Analysis of Y chromosome loss in relation to age and disease status in prostate cancer by combined PCR and FISH techniques. American Cancer Society, 4th Annual Research Conference, Ann Arbor, Michigan, September 10, 1993.

 

34.       Sakr W.A., Macoska J.A., Türkeri L., Grignon D.J., Powell I., and Wolman S.R.: Morphological and molecular analysis of prostatic carcinoma in younger males. Annual Meeting of United States and Canadian Academy of Pathology, New Orleans, Lousiana, March 13-19, 1993.

 

33.       Şimşek F., Türkeri L., Alican Y., Akdaş A.: Transurethral grooving of the prostate for the treatment of benign prostatic hyperplasia (BPH). An alternative to transurethral incision. 2nd International Congress of the Dutch Urological Association. Amsterdam, The Netherlands, November 4-6, 1993.

 

32.       Akdaş A., Alican Y., Türkeri L., Şimşek F., İlker Y., Akoğlu T.: The impact of HLA expression in men with benign prostatic hyperplasia (BPH) vs prostatic carcinoma (Pca). 2nd International Congress of the Dutch Urological Association. Amsterdam, The Netherlands, November 4-6, 1993.

 

31.       Şimşek F., Türkeri L., Erbengi T., İlker Y., Arbak S., Akdaş A.: Ultrastructural changes in the rat tissues due to electrohydraulic shock waves. 11th World Congress on Endourology. Florence, Italy, October 20-23, 1993.

 

30.       Akdaş A., Alican Y., Türkeri L., İlker Y., Akoğlu T.: HLA subtype analysis in patients with advanced adenocarcinoma of the prostate. 3rd. Mediterranean Congress of Urology, Istanbul, June 30-July 3, 1993.

 

29.       Türkeri L., Macoska J.A., Sakr W.A., Micale M.A., Powell I.J. and Pontes J.E.: Combined PCR and FISH analysis of Y chromosome loss related to age and disease status in prostate cancer. 7th Annual Meeting, Society for Basic Urologic Research. San Antonia, Texas, May 14-15, 1993.

 

28.       İlker Y., Şimşek F., Türkeri L., Alican Y., Akdaş A.: Ureteral extracorporeal shockwave lithotripsy (ESWL) utilizing Dornier MFL 5000. 10th World Congress on Endourology and ESWL, 8th Annual Research Symposium on ESWL. Singapore, September 3-6, 1992.

 

27.       İlker Y., Şimşek F., Türkeri L., Akdaş A.: Extracorporeal shock wave lithotripsy (ESWL) monotherapy in staghorn calculi with Dornier MFL 5000. 10th World Congress on Endourology and ESWL, 8th Annual Research Symposium on ESWL. Singapore, September 3-6, 1992.

 

26.       Akdaş A., Türkeri L., Gürmen N.: The role of transurethral ultrasound scanning in staging accuracy of transitional cell carcinoma of the bladder. 3rd International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment. Paris June 17-19, 1992.

 

25.       Akdaş A., Türkeri L., Alican Y., Şimşek F., Akoğlu T.: HLA subtype analysis in patients with advanced adenocarcinoma of the prostate. 3rd International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment. Paris June 17-19, 1992.

 

24.       Türkeri L., Erton M., Gürmen N., Akdaş A.: Comparative efficacy of digital rectal exam, transrectal ultrasound, and PSA levels in diagnosis of prostate cancer. 3rd International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment. Paris June 17-19, 1992.

 

23.       Küllü S., Türkeri L., Ahıskalı R., Ekicioğlu G., Şimşek F., Akdaş A.: Silver stained nucleolar organizer regions in carcinoma of the prostate. 3rd International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment. Paris June 17-19, 1992.

 

22.       Türkeri L., Şimşek F., Sav A., İlker Y., Akdaş A.: Enzymatic de-epithelialization of ileal segments used for urinary tract reconstruction. Annual Meeting of Ameican Urological Association (AUA), Washington D.C., May 10-14, 1992.

 

21.       İlker Y., Şimşek F., Türkeri L., Akdaş A. Extracorporeal shock wave lithotripsy (ESWL) monotherapy in staghorn calculi with Dornier MFL 5000. 10th World Congress on Endourology and ESWL, 8th Annual research Symposium on ESWL, Singapore, September 3-6, 1992.

 

20.       İlker Y., Şimşek F., Türkeri L., Alican Y., Akdaş A. Ureteral extracorporel shock wave lithotripsy (ESWL) utilising Dornier MFL 5000. 10th World Congress on Endourology and ESWL, 8th Annual research Symposium on ESWL, Singapore, September 3-6, 1992.

 

19.       Türkeri L., İlker Y., Şimşek F., Gümen N., Akdaş A.: Transurethral ultrasound scanning in diagnosis and staging of bladder tumors. 3rd. International Congress on Medical Ultrasound, Mediterranean and African Society of Ultrasound, Istanbul, Türkiye, April 12-15, 1992.

 

18.       Küllü S., Ersev A., Türkeri L., Gürmen N., Akdaş A. Comparison of fine needle asiration cytology and core needle biopsy in diagnosis of prostate cancer. 3rd. International Congress on Medical Ultrasound, Mediterranean and African Society of Ultrasound, Istanbul, Türkiye, April 12-15, 1992.

 

17.       Akdaş A., Gürmen N., Türkeri L., Güran S., Erton M.L.: Transrectal ultrasonography and ultrasound guided biopsies of the prostate. 3rd. International Congress on Medical Ultrasound, Mediterranean and African Society of Ultrasound, Istanbul, Türkiye, April 12-15, 1992.

 

16.       Türkeri L., Akdaş A.: The significance of bladder washout cytology in the follow-up of bladder tumors. Postgraduate course on Genito-urinary Tract Tumors, Orta San Giulio, Italy, May 27-31, 1991.

 

15.       Akdaş A., Türkeri L., Alican Y., Şimşek F., Akoğlu T.: HLA subtype analysis in patients with advanced adenocarcinoma of the prostate. 22nd Congress of the Societe Interationale D’Urologie, Sevilla, Spain, November 3-7, 1991.

 

14.       Türkeri L., Gürmen N., Akdaş A.: Digital and transrectal ultrasound guided biopsies in the peresence of palpable abnormalities of the prostate. 1st Inernational Congress of the Dutch Urological Association, “Progress and Controversies in Oncological Urology III”. Rotterdam, The Netherlands, October 9-13, 1991.

 

13.       Küllü S., Türkeri L., Ekicioğlu G., Uraz S., Akdaş A.: Prognostic value of ectopic production of human chorionic gonadotrophi in transitional cell carcinoma of the bladder. 1st Inernational Congress of the Dutch Urological Association, “Progress and Controversies in Oncological Urology III”. Rotterdam, The Netherlands, October 9-13, 1991.

 

12.       Akdaş A., Emerk K., Türkeri L., Bedir A., İlker Y., Şimşek F., Söyletir G.: Effects of Extracorporeal shockwave lithotripsy on urinary tract. 9th World Congress on Endourology and ESWL. Vienna, June 19-22, 1991 (Abs. No. XI-09).

 

11.       İlker Y., Şimşek F., Türkeri L., Akdaş A.,: Turkish experience of ureteral extracorporeal shock wave lithotripsy utilising Dornier MFL 5000. 9th World Congress on Endourology and ESWL. Vienna, June 19-22, 1991 (Abs. No. XI-08).

 

10.       Küllü S., Türkeri L., Ersev A., Ekicioğlu G., Akdaş A.: The relation of tissue prostatic acid phosphatase and prostate specific antigen with tumor grade in prostatic adenocarcinoma. 2nd Mediterranean Congress of Urology. “Markers in Urology”. Rome, July 3-6, 1991.

 

9.          Türkeri L., Erton M., Akdaş A.: Serum levels of PAP and PSA in monitoring the response to hormonal treatment in prostate cancer patients. 2nd Mediterranean Congress of Urology. “Markers in Urology”. Rome, July 3-6, 1991.

 

8.           Akdaş A., Şimşek F., İlker Y., Türkeri L.: Transurethral ultrasound scanning of the bladder. Athenian Days of Urology, Athens, Greece, May 9-12, 1991.

 

7.           Ersev A., Ersev D., Türkeri L., İlker Y., Şimşek F., Küllü S., Akdaş A. The relation of prostatic acid phosphatase and prostate specific antigen with tumor grade in prostatic adenocarcinoma: An immunohistochemical study. Consensus Conference on Prostate and Testicular Cancer. North Humberside, England, April 12-15, 1989

 

6.           Ersev A., Türkeri L., Şimşek F., Küllü S., Akdaş A.: Diagnostic value of urinary bladder washout cytology. 1st Mediterranean Congress of Urology. Rome, July 4-7, 1989 (Acta Urologica Italia Vol. III, No.3 (suppl.1): 55).

 

5.           Akdaş A., Şimşek F., İlker Y., Türkeri L., Ercan H.: The value of prostate specific antigen as serum marker in carcinoma of the prostate. 1st Marmara Medical Days. Istanbul, 26-30 September, 1988.

 

4.           Akdaş A., Şimşek F., İlker Y., Ersev D., Türkeri L.: The efficacy of Bleomycin-Etoposide-Cisplatin regimen in testicular tumors with high volume metastasis. 1st Marmara Medical Days. Istanbul, September 26-30, 1988.

 

3.           Türkeri L., Şimşek F., Ersev D., Akdaş A., Augmentin in urinary tract infections. Third Congress of Mediterranean Society of Therapy. Barcelona, September 12-15, 1988.

 

2.           Ersev D., Türkeri L., İlker Y., Şimşek F., Akdaş A.: Intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the bladder: Preliminary report. Third Congress of Mediterranean Society of Therapy. Barcelona, September 12-15, 1988.

 

1.           Akdaş A., Şimşek F., Ersev D., Türkeri L.: The efficacy of B.E.P. regimen in non-seminoma with high volume metastasis. 15th International Congress of Chemotherapy, Istanbul, July 19-24, 1987 (Abstract no. 1172).